Latest News

BOYDSense

March 15th 2025

Exciting Moments at Future4care Demo Day in Paris! We were thrilled to participate in the Future4care Demo Day in Paris, where we had the opportunity to showcase our vision and engage with an incredible community of innovators, healthcare leaders, and investors. A huge thank you to everyone who joined us, shared valuable insights, and showed interest in our work to improve the lives of people living with diabetes and pre diabetes. The energy and enthusiasm were truly inspiring! Looking forward to continuing the conversations and shaping the future together. #Future4care #DemoDay #Innovation #Healthcare #ThankYou

19

BOYDSense

March 10th 2025

Thanks for selecting BOYDSense. We are fully prepared and look forward to great discussions.

9

BOYDSense

March 10th 2025

🚀 Get ready to IGNITE innovation at #ATTD2025! 🔥 Join me at #ATTDIgnite, the must-attend session sparking the future of diabetes tech! This inspiring event sets the stage for a transformational journey, where science meets entrepreneurship, and groundbreaking ideas turn into reality. Expect a power-packed morning with: ✅ Start-up Empowerement  ✅ Exchange of ideas within the diabetes tech community ✅ Business models scalability ✅ Global networking with top experts, startups & VCs 📅 19 March | 09:00-13:00 | Hall C Don’t miss this chance to be at the forefront of diabetes innovation! 🌍💡 #DiabetesTech #Innovation #ATTDIgnite #FutureofDiabetes https://lnkd.in/eMF9-PES

16

BOYDSense

February 10th 2025

We've launched our new website! We are excited to announce the launch of our brand-new website, designed to bring you an even better experience! With: ✅ Fresh content showcasing our work ✅ A complete leadership introduction - meet the team behind the magic ✅ an engaging new video to share our science ✅ bringing even more creativity, design and collaboration This launch is a huge milestone and we couldn't have done it without our incredible BOYDSense Team and partner Recipe Design Take a look: www.boydsense.com Register for our newsletter in case you like to keep informed about BOYDSense news.

21

BOYDSense

January 9th 2025

BOYDSense is attending JPM2025. I will be attending different events supported from Business France Healthcare - North America, join the CSSi LifeSciences 11th Annual Partnering Forum and the @Resi JPM conference.

16

BOYDSense

January 9th 2025

At BOYDSense we feel honored for having received the winner award in the MedTech category at the prestigious Wlounge Tech Awards, the so named German Tech Oscar! A big thanks to WLOUNGE, especially @[Mali M Baum](urn:li:person:yMBpi7GkWz) and the jury, for nominating BOYDSense among more than 300 outstanding entrepreneurs who applied for this award. Beside this we appreciate the ongoing support from the European Innovation Council and SMEs Executive Agency (EISMEA).  #Techawards2024 #eueic #wloungetechawards

22

News

April 5th 2024

BOYDSense raises €7m in a capital increase to further develop its non-invasive glucose monitoring device.

BOYDSense, a medical device company developing a platform that makes health monitoring simple and pain free, powered by breath, announces the completion of a 7-million-euro capital increase.

Press Release

August 31st 2023

French channel France 3 report about BOYDSense solutions

The French channel France 3 dedicated a report on BOYDSense, the Alpha MOS subsidiary specialized in medical applications, that works on a pain-free device to monitor glucose levels with exhaled breath.

Press Release

July 17th 2023

The French media “La Tribune” puts BOYDSense in the spotlight

The Toulouse-based company frees diabetics from finger pricks: BOYDSense, an Alpha MOS company, is finalizing the development of an electronic breath glucose meter that could well change the lives of people with diabetes.

News

June 16th 2023

The French TV France 5 presents BOYDSense device

Dr. Pierre Gourdy, who is the investigator of the study comments: “More than 98% of the values showed high correlation between blood testing and breath measurement. The results are very promising.”

News

June 1st 2023

Conclusion of the 2nd BOYDSense clinical study

Alpha MOS, world leader in smell, taste and visual industrial instrument analyzers, announces the on-schedule completion of the 2nd clinical study on the non-invasive breath glucose monitoring device developed by its Medtech subsidiary, BOYDSense.

News

May 23rd 2023

The French radio France Inter dedicates a report to BOYDSense

In the program named “Le Zoom de la rédaction” of Tuesday, May 23rd, the journalist Sophie Bécherel gives the floor to Pierre Sbabo, CEO of Alpha MOS, and Bruno Thuillier, founder of BOYDSense.

News

February 7th 2023

BOYDSense selected among the 12 most innovative French Medtech by the National Union of the Medical Technology Industry.

BOYDSense SAS, subsidiary of Alpha MOS, has been selected by a jury from the National Union of the Medical Technology Industry (SNITEM) in order to participate to the 8th edition of the start-ups day, organized on April 4th at la Cité des Sciences.

News

December 12th 2022

BOYDSense awarded by the DCB Innovation Challenge 2022 Expert Jury

We have been recognized and awarded in the category “diabetes devices” from the DCB Innovation Challenge 2022.

Press Release

May 12th 2022

BOYDSense selected in the Top 3 Diabetes Devices of the DCB Innovation Challenge 2022

We have been selected for the final phase of the DCB Innovation Challenge 2022, in the category “diabetes devices”.

Press Release

February 3rd 2022

Ben Delhey appointed as CEO of BOYDSense, the MedTech subsidiary of Alpha MOS

We are developing a miniaturized breath analysis platform to monitor chronic diseases, with a first application in diabetes. Today we are announcing the appointment of Ben Delhey as CEO of the company.